European Journal of Epidemiology

, Volume 10, Issue 1, pp 63–68 | Cite as

Attitudes and behavior of health care personnel regarding influenza vaccination

  • D. Ballada
  • L. R. Biasio
  • G. Cascio
  • D. D'Alessandro
  • I. Donatelli
  • G. M. Fara
  • T. Pozzi
  • M. L. Profeta
  • S. Squarcione
  • D. Riccò
  • T. Todisco
  • F. Vacca
Article

Abstract

This paper reports the results of a study conducted by the Italian Association for Immuneprophylaxis promotion (AIPI) with the aim of surveying the attitudes and perceptions of Italian health care workers regarding the use and efficacy of influenza vaccine. The results clearly show that a high proportion of the questioned health care workers showed a general lack of concern about the severity of the disease. Doubts about vaccine efficacy and fear of post-vaccination side effects were also observed to have an important influence on the vaccination acceptance rates. These data underline the need for a systematic education program to provide influenza vaccination within the public and private health-care sectors in Italy.

Key words

Influenza vaccination promotion Medicare personnel behavior 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barker WH. Excess pneumonia and influenza associated with hospitalization during influenza epidemics in the United States, 1970–1978. Am J Public Healt 1986; 76: 761–765.Google Scholar
  2. 2.
    Fedson DS. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Clin Geriac Med 1992; 8: 183–199.Google Scholar
  3. 3.
    Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25–44.Google Scholar
  4. 4.
    Immunization Practices Advisory Commitee. Prevention and control of influenza. MMWR 1992; 41: 1–17.Google Scholar
  5. 5.
    Mostov SR, Cate TR, Ruben FL. Prevention of influenza and pneumonia. Am Rev Respir Dis 1990; 142: 487–488.Google Scholar
  6. 6.
    Schoenbaum SC. Economic impact of influenza: The individual's perspective. Am J Med 1987; 82: 26–30.Google Scholar
  7. 7.
    Arden NH, Patriarca PA, Fasano MB, Lui KJ, Harmon MW, Kendal AP, Rimland D. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988; 148: 865–868.Google Scholar
  8. 8.
    Patriarca PA, Arden NH, Koplan JP, Goodman RA. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 1987; 107: 732–740.Google Scholar
  9. 9.
    Patriarca PA, Weber JA, Parker RA, Hall WN, Kendal AP, Bregman DJ, Schonberger LB. Efficacy of influenza vaccine in nursing homes. JAMA 1985; 253: 1136.Google Scholar
  10. 10.
    Douglas RG Jr. Prophylaxis and treatment of influenza. N Engl J Med 1990; 322: 443.Google Scholar
  11. 11.
    Heilman C, La Montagne JR. Influenza: Status and prospects for its prevention, therapy, and control. Ped Clin N Am 1990; 37: 669–676.Google Scholar
  12. 12.
    Kilbourne ED. Inactivated influenza vaccines. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. Philadelphia: WB Saunders, 1988: 420–432.Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • D. Ballada
    • 2
    • 1
  • L. R. Biasio
    • 3
    • 1
  • G. Cascio
    • 4
    • 1
  • D. D'Alessandro
    • 5
    • 1
  • I. Donatelli
    • 6
    • 1
  • G. M. Fara
    • 5
    • 1
  • T. Pozzi
    • 8
    • 1
  • M. L. Profeta
    • 9
    • 1
  • S. Squarcione
    • 2
    • 1
  • D. Riccò
    • 10
    • 1
  • T. Todisco
    • 11
    • 1
  • F. Vacca
    • 7
    • 1
  1. 1.Italian Association for Immune-Prophylaxis Promotion (AIP.I)Italy
  2. 2.Ministero SanitàRome
  3. 3.Istituto Merieux ItaliaRome
  4. 4.Istituto Malattie Infettive Università degli StudiPalermo
  5. 5.Istituto d'Igiene Università ‘La Sapienza’Rome
  6. 6.Istituto Superiore di SanitàRomeItaly
  7. 7.USL 10Iesi
  8. 8.Istituto Vaccinogeno T. PozziItaly
  9. 9.Istituto di Virologia UniversitàMilano
  10. 10.USL 4Parma
  11. 11.Unità Organica di PneumologiaPerugia

Personalised recommendations